A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 180.81 US$, with a 24-hour trading volume of 27.83M US$. The asset's market cap is 281.08B US$, after moving -1.44% in the last day.
Tokenized AstraZeneca PLC is trading at 101.15 US$, with a tokenized market cap of 13.85M US$ and a 24-hour trading volume of 813.86K US$. The tokenized asset has moved -3.34% in the past 24 hours.